genetics

30 April 2003

J. Cotter & A. Lorch, Greenpeace, April 2003.

50 years ago the structure of DNA was determined 1 and hailed as the “secret of life”. The determination of the structure of DNA made it seem as if the complete understanding of living organisms was possible, even though fundamental questions regarding DNA function were unanswered, and remain so today. Later, in the 1970s and 1980s, the technology to insert genes at random into the genomes of organisms were developed and termed genetic engineering (GE). Genetic engineering was hailed as a “life” science, as a technology to shape and design living organisms as required. Some GE crops have now been commercialised by the GE industry and deliberately released to the environment. Unexpected effects occurring in GE organisms, including commercial GE crops, are regarded as technical problems to be overcome by more research or adapted technologies. However, these unexpected effects may be due to more a more fundamental reason – that the basis of GE is invalid. In the 50 years since the discovery of the double helix, science has shown that gene expression is not nearly as simple as the GE industry would like to believe.

30 September 2000

A. Lorch, BioSkop September 2000.

Die so genannte "Entschlüsselung" des menschlichen Genoms regt seit Juni 2000 die Fantasie von Wissenschaft, Politik und Medien an: Die Rede ist von Parallelen zur ersten Mondlandung, von der bedeutendsten Leistung seit der Erfindung des Rades, von Gottes Handschrift, die nun lesbar sei. Doch bis heute wissen GenforscherInnen nicht, was ein Gen genau ist. Was wurde da der Öffentlichkeit überhaupt präsentiert?

20 December 1999

V. Lehmann & A. Lorch, Biotechnology and Development Monitor December 1999.

With the sequencing of the entire human genome coming closer by the day, the implications resulting from the exploitation of this information are becoming clearer. Intellectual property claims play an important role in the race between private and public sequencing efforts. While pharmaceutical companies are eager to use the generated knowledge to optimize drug development strategies, these will most likely neglect the intrests of developing countries.

Powered by Drupal, an open source content management system